Quantitative Structure Activity Relationship between Diazabicyclo-[4.2.0]octanes Derivatives and Nicotinic Acetylcholine Receptor Agonists |
Kim, Eun-Ae
(College of Pharmacy, Chung-Ang University)
Jung, Kyoung-Chul (College of Pharmacy, Chung-Ang University) Sohn, Uy-Dong (College of Pharmacy, Chung-Ang University) Im, Chae-Uk (College of Pharmacy, Chung-Ang University) |
1 | Cashin AL, Torrice MM, McMenimen KA, Lester HA, Dougherty DA. Chemical-scale studies on the role of a conserved aspartate in preorganizing the agonist binding site of the nicotinic acetylcholine receptor. Biochemistry 46: 630-639, 2007 DOI ScienceOn |
2 | Girod R, Barazangi N, McGehee D, Role LW. Facilitation of glutamatergic neurotransmission by presynaptic nicotinic acetylcholine receptors. Neuropharmacology 39: 2715-2725, 2000 DOI ScienceOn |
3 | Hays JT, Ebbert J, Sood A. Efficacy and safety of varenicline for smoking cessation. Am J Med 121: S32-S42, 2008 PUBMED |
4 | Lape R, Colquhoun D, Sivilotti LG. On the nature of partial agonism in the nicotinic receptor superfamily. Nature 454: 722-727, 2008 PUBMED ScienceOn |
5 | Dougherty JJ, Wu J, Nichols RA. -Amyloid regulation of presynaptic nicotinic receptors in rat hippocampus and neocortex. J Neurosci 23: 6740-6747, 2003 |
6 | Frost MJ, Bunnelle HW, Tietje KR, Anderson DJ, Rueter LE, Curzon P, Surowy CS, Jerome JJ, Kohlhaas DK, Buckley MJ, Henry RF, Dyhring T, Ahring PK, Meyer MD. Synthesis and structure-activity relationships of 3,8-diazabicyclo'4.2.0'octane ligands, potent nicotinic acetylcholine receptor agonists. J Med Chem 49: 7843-7853, 2006 DOI ScienceOn |
7 | Vincler M, McIntosh JM. Targeting the 9 10 nicotinic acetylcholine receptor to treat severe pain. Expert Opinion on Therapeutic Targets 11: 891-897, 2007 DOI ScienceOn |
8 | Dehkordi O, Millis RM, Dennis GC, Jazini E, Williams C, Hussain D, Jayam-Trouth A. Expression of -7 and -4 nicotinic acetylcholine receptors by GABAergic neurons of rostral ventral medulla and caudal pons. Brain Res 1185: 95-102, 2007 |
9 | Jensen AA, Frolund B, Liljefors T, Krogsgaard LP. Neuronal nicotinic acetylcholine receptors: structural revelations, target identifications, and therapeutic inspirations. J Med Chem 48: 4705-4745, 2005 DOI ScienceOn |
10 | Kuryatov A, Onksen J, Lindstrom J. Roles of accessory subunits in 42 nicotinic receptors. Molecular Pharmacology 74: 132-143, 2008 DOI PUBMED ScienceOn |
11 | Grady SR, Salminen O, Laverty DC, Whiteaker P, McIntosh JM, Collins AC, Marks MJ. The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum. Biochem Pharmacol 74: 1235-1246, 2007 DOI ScienceOn |
12 | SYBYL Molecular Modeling Software. Tripos Inc., St. Louis, USA, 2008 |
13 | Hogg RC, Bertrand D. Neuroscience: What genes tell us about nicotine addiction. Science 306: 983-985, 2004 DOI PUBMED ScienceOn |
14 | Gotti C, Zoli M, Clementi F. Brain nicotinic acetylcholine receptors: native subtypes and their relevance Trends. Pharmacol Sci 27: 482-491, 2006 DOI ScienceOn |
15 | Owen RT, Serradell N, Rosa E. Ispronicline: nicotinic acetylcholine 42 agonist treatment of cognition disorders. Drugs of the Future 33: 197-202, 2008 DOI |
16 | Pons S, Fattore L, Cossu G, Tolu S, Porcu E, McIntosh JM, Changeux JP, Maskos U, Fratta W. Crucial role of 4 and 6 nicotinic acetylcholine receptor subunits from ventral tegmental area in systemic nicotine self-administration. J Neurosci 28: 12318-12327, 2008 DOI ScienceOn |
17 | Kenny PJ, File SE, Neal MJ. Evidence for a complex influence of nicotinic acetylcholine receptors on hippocampal serotonin release. J Neurochem 75: 2409-2414, 2000 DOI ScienceOn |
18 | O'Leary KT, Parameswaran N, Johnston LC, McIntosh JM, Di Monte DA, Quik M. Paraquat exposure reduces nicotinic receptor-evoked dopamine release in monkey striatum. J Pharmacol Exp Ther 327: 124-129, 2008 DOI ScienceOn |